
Eargo EAR
Quarterly report 2023-Q3
added 11-07-2023
Eargo Interest Expense 2011-2026 | EAR
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Eargo
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 549 K | 1.07 M | 1.92 M | 711 K | 424 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.92 M | 424 K | 934 K |
Quarterly Interest Expense Eargo
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 549 K | 285 K | 264 K | - | 269 K | 266 K | 263 K | - | 279 K | 877 K | 266 K | - | 218 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 877 K | 218 K | 354 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Inogen
INGN
|
2.44 M | $ 6.32 | -2.02 % | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
164 K | $ 99.89 | 0.69 % | $ 1.27 B | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 63.27 | 0.05 % | $ 3.45 B | ||
|
LENSAR
LNSR
|
660 K | $ 5.71 | -5.93 % | $ 65.8 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
AxoGen
AXGN
|
167 K | $ 32.42 | 2.11 % | $ 1.49 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.72 | 0.25 % | $ 1.14 B | ||
|
Medtronic PLC
MDT
|
402 M | $ 86.65 | -0.64 % | $ 111 B | ||
|
Electromed
ELMD
|
78 K | $ 24.67 | 0.73 % | $ 209 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.15 | -6.52 % | $ 3.36 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
8.11 M | $ 11.77 | -0.84 % | $ 466 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.48 | 10.66 % | $ 1.55 B | ||
|
Myomo
MYO
|
-668 K | $ 0.69 | -2.17 % | $ 28.9 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.85 | 3.08 % | $ 144 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.84 | -3.83 % | $ 372 M | ||
|
Penumbra
PEN
|
893 K | $ 334.58 | -0.3 % | $ 13 B | ||
|
Outset Medical
OM
|
14 M | $ 3.49 | -3.6 % | $ 53.1 K | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 51.53 | -1.3 % | $ 1.51 B | ||
|
Insulet Corporation
PODD
|
14.3 M | $ 225.21 | -0.82 % | $ 15.8 B | ||
|
Profound Medical Corp.
PROF
|
146 K | $ 5.1 | -5.56 % | $ 180 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.33 | -4.68 % | $ 54.1 M | ||
|
Quanterix Corporation
QTRX
|
157 K | $ 3.68 | -6.73 % | $ 157 M | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
InspireMD
NSPR
|
200 K | $ 1.8 | 4.05 % | $ 116 M |